{"product_id":"hoya-swot-analysis","title":"HOYA SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDive Deeper Into the Company’s Strategic Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eHOYA’s diversified healthcare and imaging portfolio, strong R\u0026amp;D pipeline, and resilient revenue streams position it well for secular growth, while exposure to cyclical optical markets and integration risks merit close attention—purchase the full SWOT analysis to access a detailed, editable report with financial context and strategic recommendations tailored for investors and advisors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominance in EUV Mask Blanks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHOYA holds roughly 60–70% global share in EUV mask blanks as of 2025, supplying key players like TSMC and Samsung and generating about ¥60–80 billion (~$400–550M) annual revenue from this segment in FY2024.\u003c\/p\u003e\n\u003cp\u003eAs chip nodes push below 3nm for AI and HPC, HOYA’s specialized polishing and defect-control tech forms a durable moat, creating multi-year contracts and high capital\/know-how barriers for entrants.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarket Leadership in Medical Endoscopes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThrough PENTAX Medical, HOYA is a global leader in flexible endoscopes, with the endoscopy segment contributing roughly ¥80 billion (about $570M) to HOYA’s FY2024 sales and showing ~6% annual growth in 2023–24; clinicians cite PENTAX’s integrated high‑definition and narrow‑band imaging for better lesion detection and shorter procedure times. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Precision Glass Technology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHOYA’s world-class glass melting and molding expertise underpins products from eyeglass lenses to HDD substrates, supporting FY2024 optical segment sales of ¥253.4bn (about $1.8bn). This core skill enables consistent, high-quality output that meets healthcare and IT standards, yielding a 12.8% operating margin in imaging \u0026amp; healthcare in 2024. Ongoing materials-science R\u0026amp;D—~¥23bn spent in FY2024—keeps HOYA at the optical-performance forefront.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrong Portfolio Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eHOYA uses a decentralized model that treats businesses like an investment portfolio, reallocating capital to high-growth units and exiting non-core assets; this drove ROE of ~15.8% in FY2024 and total shareholder return of ~48% over 2019–2024.\u003c\/p\u003e\n\u003cp\u003eThat agility produced consistent value creation—cash ROIC for optical and medical segments rose to ~12.5% in 2024, and management completed multiple divestments raising ¥120 billion in 2023–2024.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math: reallocating ¥120B led to reinvestment in higher-margin medical optics, lifting group EBIT margin by ~180 bps in FY2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDecentralized portfolio approach\u003c\/li\u003e\n\u003cli\u003eFY2024 ROE ~15.8%\u003c\/li\u003e\n\u003cli\u003e2019–2024 TSR ~48%\u003c\/li\u003e\n\u003cli\u003e¥120B divested 2023–2024\u003c\/li\u003e\n\u003cli\u003eGroup EBIT margin +180 bps FY2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distribution Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eHOYA maintains manufacturing sites and sales offices across Asia, Europe, and the Americas, supporting FY2024 revenue of ¥758.8 billion (about $5.1B) and 9% YoY product-sales growth in vision care.\u003c\/p\u003e\n\u003cp\u003eThis global footprint helps dampen regional downturns—Asia accounted for ~46% of sales in 2024—while keeping teams close to diverse customers and regulators.\u003c\/p\u003e\n\u003cp\u003eIt also speeds rollouts: HOYA launched new intraocular lenses and premium eyeglass coatings in 15+ markets during 2024, shortening time-to-revenue.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFY2024 revenue ¥758.8B (~$5.1B)\u003c\/li\u003e\n\u003cli\u003eAsia ~46% of sales\u003c\/li\u003e\n\u003cli\u003e15+ markets for 2024 product launches\u003c\/li\u003e\n\u003cli\u003e9% YoY vision-care growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHOYA: EUV dominance, ¥758.8bn FY24, strong optics \u0026amp; medtech margins, ~16% ROE\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHOYA’s strengths: dominant EUV mask-blank share (60–70% in 2025) with ¥60–80bn revenue FY2024; leading PENTAX endoscopy (~¥80bn, ~6% growth); optical segment ¥253.4bn and 12.8% imaging \u0026amp; healthcare margin; FY2024 group revenue ¥758.8bn, ROE ~15.8%, TSR 2019–24 ~48%, ¥120bn divested 2023–24.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 revenue\u003c\/td\u003e\n\u003ctd\u003e¥758.8bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEUV share (2025)\u003c\/td\u003e\n\u003ctd\u003e60–70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOptical sales FY2024\u003c\/td\u003e\n\u003ctd\u003e¥253.4bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePENTAX endoscopy\u003c\/td\u003e\n\u003ctd\u003e¥80bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D FY2024\u003c\/td\u003e\n\u003ctd\u003e¥23bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eROE FY2024\u003c\/td\u003e\n\u003ctd\u003e~15.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTSR 2019–24\u003c\/td\u003e\n\u003ctd\u003e~48%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDivestments 2023–24\u003c\/td\u003e\n\u003ctd\u003e¥120bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise SWOT assessment of HOYA, outlining its core strengths and weaknesses while identifying market opportunities and external threats shaping its strategic outlook.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise HOYA SWOT summary for fast, visual strategy alignment and quick stakeholder briefings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDependency on Semiconductor Cycles\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpa significant portion of hoya earnings fy2024 revenue per report from semiconductor-related products exposing results to the sector deep cycles and demand swings. while euv mask blanks drove strong h2 sales a tech slowdown could force customers cut orders run down inventory trimming near-term sales. that exposure makes information technology segment quarterly operating margin volatile for example fell yoy in q3 fy2023 during industry weakness. what this estimate hides: timing fabs long lead-times can amplify bumps.\u003e\n\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVulnerability to Cyber Disruptions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHoya suffered a major IT outage in 2021 after unauthorized access disrupted production; similar breaches cost the medical device sector an average $5.2M per incident in 2023, so knock-on production delays and remediation could hit Hoya's margins materially.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Concentration in HDD Substrates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHOYA supplies glass substrates for HDDs, a market down ~60% in unit shipments since 2015 as SSD adoption rose; HDD revenue fell 12% YoY in 2024 industry data, concentrating HOYA exposure. Data centers still buy high-capacity HDDs (15–22TB) but consumer demand has shrunk sharply, risking revenue if flash transition accelerates beyond current 5–7% annual CAGR for HDD capacity. Over-reliance on this niche could push margin volatility and impair growth unless HOYA diversifies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComplex Regulatory Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAs a major medical-device player, HOYA must navigate differing FDA, EMA and PMDA rules; in 2024 regulatory delays cost medical-device firms an average 18% longer time-to-market, risking missed revenue windows for HOYA’s €3.1bn vision-care segment (FY2024 sales).\u003c\/p\u003e\n\u003cp\u003eFDA or EMA approval delays can raise development costs—industry median overruns hit 12%—and push launches past competitive cycles.\u003c\/p\u003e\n\u003cp\u003eNon-compliance risks recalls and fines; a 2023 EU device recall wave showed reputational damage cutting short-term sales by up to 7% for affected firms.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMultiple regulators: FDA, EMA, PMDA\u003c\/li\u003e\n\u003cli\u003eTime-to-market delays: ~18% (2024 industry avg)\u003c\/li\u003e\n\u003cli\u003eCost overruns: ~12% median\u003c\/li\u003e\n\u003cli\u003eRecall impact: up to 7% short-term sales drop\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSensitivity to Raw Material Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cphoya production of high-end optical glass depends on rare earths and specialty chemicals whose prices rose yoy in for key inputs like neodymium cerium squeezing gross margins reported a margin\u003e\n\u003cp\u003eGeopolitical tensions with China and export controls risk supplier access, raising procurement costs and necessitating larger working capital and inventory buffers; sourcing shifts would require significant CapEx and strategic planning.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003eRare earth input prices +18% in 2024\u003c\/li\u003e\u003cli\u003eHOYA 2024 gross margin ~41.2%\u003c\/li\u003e\u003cli\u003eHigher working capital and CapEx needed\u003c\/li\u003e\n\u003c\/phoya\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHOYA margin squeeze: semiconductor exposure, HDD slump, rising costs \u0026amp; delays\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cphoya faces cyclical semiconductor exposure of fy2024 revenue hdd demand decline market units since yoy regulatory delays raising time-to-market industry avg and cost overruns supply-cost pressure from rare-earths input prices squeezing gross margin\u003e\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSemiconductor share of revenue\u003c\/td\u003e\n\u003ctd\u003e~27% FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHOYA gross margin\u003c\/td\u003e\n\u003ctd\u003e~41.2% FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRare-earth input price change\u003c\/td\u003e\n\u003ctd\u003e+18% YoY 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHDD market unit change since 2015\u003c\/td\u003e\n\u003ctd\u003e-60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHDD revenue change 2024\u003c\/td\u003e\n\u003ctd\u003e-12% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory time-to-market impact\u003c\/td\u003e\n\u003ctd\u003e+18% (2024 industry avg)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevelopment cost overruns\u003c\/td\u003e\n\u003ctd\u003e~12% median\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/phoya\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eHOYA SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual HOYA SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality and ready-to-use insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752324968825,"sku":"hoya-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/hoya-swot-analysis.png?v=1772239530","url":"https:\/\/matrixbcg.com\/products\/hoya-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}